Encompass Health Corporation which can be found using ticker (EHC) have now 11 analysts in total covering the stock. The consensus rating is pointing to ‘Buy’. The range between the high target price and low target price is between 75 and 61 suggesting an average Analsyt target price of $70.09. Given that the stocks previous close was at $61.86 this indicates there is a potential upside of 13.3%. It’s also worth noting that there is a 50 day moving average of $57.37 while the 200 day moving average is $54.44. The company has a market capitalization of $6,122m. Find out more information at: https://www.encompasshealth.com
The potential market cap would be $6,937m based on the market consensus.
Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides services under the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.
The company has a dividend yield of 0.98% with the ex dividend date set at 31-3-2023 (DMY).
Other points of data to note are a P/E ratio of 23.98, revenue per share of 43.84 and a 6.3% return on assets.
